365 related articles for article (PubMed ID: 17974270)
1. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
[TBL] [Abstract][Full Text] [Related]
2. [Construction of a recombinant adenovirus vector harboring human transforming growth factor-beta type II receptor-IgG1Fc fusion gene].
Jia L; Xue JX; Lu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2136-8. PubMed ID: 19114339
[TBL] [Abstract][Full Text] [Related]
3. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
4. [Construction of recombinant adenovirus vector pAdxsi-green fluorescent protein-homo sapiens NEL-like 1 and transfected into rat bone marrow mesenchymal stem cells].
Xue J; Peng J; Zhang L; Liu S; Chen J; Wang A; Yuan M; Xu W; Lu S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 May; 24(5):606-12. PubMed ID: 20540270
[TBL] [Abstract][Full Text] [Related]
5. The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma.
Li J; Liu H; Li L; Wu H; Wang C; Yan Z; Wang Y; Su C; Jin H; Zhou F; Wu M; Qian Q
Oncol Rep; 2013 Mar; 29(3):895-902. PubMed ID: 23292657
[TBL] [Abstract][Full Text] [Related]
6. [Construction of CYP2E1 recombinant adenovirus vector and its anti-tumor effects].
Wang JS; Hu XY; Zhang W; Yuan J; Yang Y; Fang Q
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2130-5. PubMed ID: 21029630
[TBL] [Abstract][Full Text] [Related]
7. [CONSTRUCTION AND IDENTIFICATION OF ADENOVIRUS VECTOR EXPRESSING BONE MORPHOGENETIC PROTEIN 2 AND TRANSFORMING GROWTH FACTOR β3 GENES AND THEIR EXPRESSION IN BONE MARROW MESENCHYMAL STEM CELLS OF DIANNAN SMALL-EAR PIGS].
Wang X; Li Y; Jin Y; Chen J; Wang H; He C; Cao S; Zhao F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):896-902. PubMed ID: 26462358
[TBL] [Abstract][Full Text] [Related]
8. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene.
Haiping Z; Takayama K; Uchino J; Harada A; Adachi Y; Kura S; Caicun Z; Tsuzuki T; Nakanishi Y
Cancer Gene Ther; 2006 Sep; 13(9):864-72. PubMed ID: 16710346
[TBL] [Abstract][Full Text] [Related]
9. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
10. Growth suppression of human lung cancer cells and implanted tumors by adenovirus-mediated transfer of the PTEN gene.
Chen Z; Yang J
J Huazhong Univ Sci Technolog Med Sci; 2010 Apr; 30(2):149-54. PubMed ID: 20407863
[TBL] [Abstract][Full Text] [Related]
11. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
[TBL] [Abstract][Full Text] [Related]
12. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lung adenocarcinoma transfected with interleukin 28A recombinant adenovirus (Ad-mIFN-λ2) in vivo.
Yan Y; Zhang J; Liu Y; Zhu T; Yuan L; Ge Y; Ding H; Bu X
Cancer Biother Radiopharm; 2013 Mar; 28(2):124-30. PubMed ID: 23134221
[TBL] [Abstract][Full Text] [Related]
15. [Construction and identification of nemo-like kinase gene recombinant adenovirus vector].
Cheng XW; Liang JB; Miao SY; Wang LF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Dec; 33(6):632-7. PubMed ID: 22509546
[TBL] [Abstract][Full Text] [Related]
16. [Construction of Recombinant Adenovirus Vector with Human/Mouse Interferon Gene and Its Transfection into Human Umbilical Cord Mesenchymal Stem Cells].
Li H; Hu QY; Jia YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):805-10. PubMed ID: 26867311
[TBL] [Abstract][Full Text] [Related]
17. [Construction of rat bowel transforming growth factor beta1 recombinant adenovirus vector].
Li JP; Huang Y; Wang WZ; Dong GL; DU JJ; Chen DL; Ji G; Liu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):76-9. PubMed ID: 18197501
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells.
Engel JD; Kundu SD; Yang T; Lang S; Goodwin S; Janulis L; Cho JS; Chang J; Kim SJ; Lee C
Urology; 1999 Jul; 54(1):164-70. PubMed ID: 10414746
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
20. Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy.
Seth P; Wang ZG; Pister A; Zafar MB; Kim S; Guise T; Wakefield L
Hum Gene Ther; 2006 Nov; 17(11):1152-60. PubMed ID: 17032151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]